Search alternatives:
larger decrease » marked decrease (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
larger decrease » marked decrease (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
4841
Image1_RETRACTED: Effect of histone deacetylase inhibitors trichostatin A and valproic acid on hair cell regeneration in zebrafish lateral line neuromasts.JPEG
Published 2024“…Additionally, BrdU immunostaining and western blot analysis showed that TSA or VPA treatment caused a significant decrease in the percentage of S-phase cells and induced p21<sup>Cip1</sup> and p27<sup>Kip1</sup> expression, both of which are likely to explain the decrease in the amount of newly regenerated hair cells in treated embryos. …”
-
4842
Image2_RETRACTED: Effect of histone deacetylase inhibitors trichostatin A and valproic acid on hair cell regeneration in zebrafish lateral line neuromasts.JPEG
Published 2024“…Additionally, BrdU immunostaining and western blot analysis showed that TSA or VPA treatment caused a significant decrease in the percentage of S-phase cells and induced p21<sup>Cip1</sup> and p27<sup>Kip1</sup> expression, both of which are likely to explain the decrease in the amount of newly regenerated hair cells in treated embryos. …”
-
4843
Table1_RETRACTED: Effect of histone deacetylase inhibitors trichostatin A and valproic acid on hair cell regeneration in zebrafish lateral line neuromasts.PDF
Published 2025“…Additionally, BrdU immunostaining and western blot analysis showed that TSA or VPA treatment caused a significant decrease in the percentage of S-phase cells and induced p21<sup>Cip1</sup> and p27<sup>Kip1</sup> expression, both of which are likely to explain the decrease in the amount of newly regenerated hair cells in treated embryos. …”
-
4844
Image3_RETRACTED: Effect of histone deacetylase inhibitors trichostatin A and valproic acid on hair cell regeneration in zebrafish lateral line neuromasts.JPEG
Published 2024“…Additionally, BrdU immunostaining and western blot analysis showed that TSA or VPA treatment caused a significant decrease in the percentage of S-phase cells and induced p21<sup>Cip1</sup> and p27<sup>Kip1</sup> expression, both of which are likely to explain the decrease in the amount of newly regenerated hair cells in treated embryos. …”
-
4845
Table1_RETRACTED: Effect of histone deacetylase inhibitors trichostatin A and valproic acid on hair cell regeneration in zebrafish lateral line neuromasts.PDF
Published 2024“…Additionally, BrdU immunostaining and western blot analysis showed that TSA or VPA treatment caused a significant decrease in the percentage of S-phase cells and induced p21<sup>Cip1</sup> and p27<sup>Kip1</sup> expression, both of which are likely to explain the decrease in the amount of newly regenerated hair cells in treated embryos. …”
-
4846
Image3_RETRACTED: Effect of histone deacetylase inhibitors trichostatin A and valproic acid on hair cell regeneration in zebrafish lateral line neuromasts.JPEG
Published 2025“…Additionally, BrdU immunostaining and western blot analysis showed that TSA or VPA treatment caused a significant decrease in the percentage of S-phase cells and induced p21<sup>Cip1</sup> and p27<sup>Kip1</sup> expression, both of which are likely to explain the decrease in the amount of newly regenerated hair cells in treated embryos. …”
-
4847
Table1_RETRACTED: Effect of histone deacetylase inhibitors trichostatin A and valproic acid on hair cell regeneration in zebrafish lateral line neuromasts.PDF
Published 2024“…Additionally, BrdU immunostaining and western blot analysis showed that TSA or VPA treatment caused a significant decrease in the percentage of S-phase cells and induced p21<sup>Cip1</sup> and p27<sup>Kip1</sup> expression, both of which are likely to explain the decrease in the amount of newly regenerated hair cells in treated embryos. …”
-
4848
Table1_RETRACTED: Effect of histone deacetylase inhibitors trichostatin A and valproic acid on hair cell regeneration in zebrafish lateral line neuromasts.PDF
Published 2024“…Additionally, BrdU immunostaining and western blot analysis showed that TSA or VPA treatment caused a significant decrease in the percentage of S-phase cells and induced p21<sup>Cip1</sup> and p27<sup>Kip1</sup> expression, both of which are likely to explain the decrease in the amount of newly regenerated hair cells in treated embryos. …”
-
4849
Image1_RETRACTED: Effect of histone deacetylase inhibitors trichostatin A and valproic acid on hair cell regeneration in zebrafish lateral line neuromasts.JPEG
Published 2024“…Additionally, BrdU immunostaining and western blot analysis showed that TSA or VPA treatment caused a significant decrease in the percentage of S-phase cells and induced p21<sup>Cip1</sup> and p27<sup>Kip1</sup> expression, both of which are likely to explain the decrease in the amount of newly regenerated hair cells in treated embryos. …”
-
4850
Image1_RETRACTED: Effect of histone deacetylase inhibitors trichostatin A and valproic acid on hair cell regeneration in zebrafish lateral line neuromasts.JPEG
Published 2024“…Additionally, BrdU immunostaining and western blot analysis showed that TSA or VPA treatment caused a significant decrease in the percentage of S-phase cells and induced p21<sup>Cip1</sup> and p27<sup>Kip1</sup> expression, both of which are likely to explain the decrease in the amount of newly regenerated hair cells in treated embryos. …”
-
4851
Image2_RETRACTED: Effect of histone deacetylase inhibitors trichostatin A and valproic acid on hair cell regeneration in zebrafish lateral line neuromasts.JPEG
Published 2024“…Additionally, BrdU immunostaining and western blot analysis showed that TSA or VPA treatment caused a significant decrease in the percentage of S-phase cells and induced p21<sup>Cip1</sup> and p27<sup>Kip1</sup> expression, both of which are likely to explain the decrease in the amount of newly regenerated hair cells in treated embryos. …”
-
4852
Image2_RETRACTED: Effect of histone deacetylase inhibitors trichostatin A and valproic acid on hair cell regeneration in zebrafish lateral line neuromasts.JPEG
Published 2025“…Additionally, BrdU immunostaining and western blot analysis showed that TSA or VPA treatment caused a significant decrease in the percentage of S-phase cells and induced p21<sup>Cip1</sup> and p27<sup>Kip1</sup> expression, both of which are likely to explain the decrease in the amount of newly regenerated hair cells in treated embryos. …”
-
4853
Image2_RETRACTED: Effect of histone deacetylase inhibitors trichostatin A and valproic acid on hair cell regeneration in zebrafish lateral line neuromasts.JPEG
Published 2024“…Additionally, BrdU immunostaining and western blot analysis showed that TSA or VPA treatment caused a significant decrease in the percentage of S-phase cells and induced p21<sup>Cip1</sup> and p27<sup>Kip1</sup> expression, both of which are likely to explain the decrease in the amount of newly regenerated hair cells in treated embryos. …”
-
4854
Image1_RETRACTED: Effect of histone deacetylase inhibitors trichostatin A and valproic acid on hair cell regeneration in zebrafish lateral line neuromasts.JPEG
Published 2025“…Additionally, BrdU immunostaining and western blot analysis showed that TSA or VPA treatment caused a significant decrease in the percentage of S-phase cells and induced p21<sup>Cip1</sup> and p27<sup>Kip1</sup> expression, both of which are likely to explain the decrease in the amount of newly regenerated hair cells in treated embryos. …”
-
4855
Image3_RETRACTED: Effect of histone deacetylase inhibitors trichostatin A and valproic acid on hair cell regeneration in zebrafish lateral line neuromasts.JPEG
Published 2024“…Additionally, BrdU immunostaining and western blot analysis showed that TSA or VPA treatment caused a significant decrease in the percentage of S-phase cells and induced p21<sup>Cip1</sup> and p27<sup>Kip1</sup> expression, both of which are likely to explain the decrease in the amount of newly regenerated hair cells in treated embryos. …”
-
4856
-
4857
S1 Data -
Published 2024“…Compared to the SD, the HFD and SDG models exhibited significantly increased and decreased contraction velocities and could be used as models of diarrhoea and constipation in DM, respectively, while the ED model showed comparatively little change in motility. …”
-
4858
Specifications of prototypes of RSSCA system.
Published 2025“…Compared to conventional PV systems, the RSSCA offers improved light uniformity, better land-use efficiency, and significantly higher electricity generation. However, in regions with limited direct sunlight, such as Seoul in winter, system performance decreases. …”
-
4859
Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms
Published 2025“…In ovariectomized mice, <b>5cc</b> administration (5 mg/kg) improved the trabecular microarchitecture, bone mineral density, and strength, at levels comparable to teriparatide, while significantly reducing bone resorption markers. With 13.57% oral bioavailability and selectivity for PDE1A1 (32% inhibition at 500 nM), <b>5cc</b> offers an innovative therapeutic candidate for PMO with a dual anabolic-antiresorptive profile and oral efficacy, warranting further clinical development.…”
-
4860
Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms
Published 2025“…In ovariectomized mice, <b>5cc</b> administration (5 mg/kg) improved the trabecular microarchitecture, bone mineral density, and strength, at levels comparable to teriparatide, while significantly reducing bone resorption markers. With 13.57% oral bioavailability and selectivity for PDE1A1 (32% inhibition at 500 nM), <b>5cc</b> offers an innovative therapeutic candidate for PMO with a dual anabolic-antiresorptive profile and oral efficacy, warranting further clinical development.…”